Identification | More | [Name]
(S)-N-Boc-3-Bromophenylalanine | [CAS]
82278-73-7 | [Synonyms]
BOC-3-BROMO-L-PHENYLALANINE BOC-L-3-BROMOPHE BOC-L-3-BROMOPHENYLALANINE BOC-PHE(3-BR)-OH BOC-S-PHE(3-BR)-OH N-ALPHA-T-BUTOXYCARBONYL-3-BROMO-L-PHENYLALANINE N-TERT-BUTOXYCARBONYL-3-BROMOPHENYL-L-ALANINE (S)-3-(3-BROMO-PHENYL)-2-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID (S)-N-ALPHA-T-BUTYLOXYCARBONYL-3-BROMO-PHENYLALANINE (S)-N-BOC-3-BROMOPHENYLALANINE N-TERT-BUTOXYCARBONYL-L-3-BROMO PHENYLALANINE BOC-L-3-BROMOPHENYLALANINE 98% (S)-N-BOC-3-Bromophenylalanine, 98% ee, 95% | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C14H18BrNO4 | [MDL Number]
MFCD01317710 | [Molecular Weight]
344.2 | [MOL File]
82278-73-7.mol |
Chemical Properties | Back Directory | [Appearance]
off-white powder | [Melting point ]
106.1°C | [Boiling point ]
475.3±40.0 °C(Predicted) | [density ]
1.5311 (rough estimate) | [refractive index ]
1.6500 (estimate) | [storage temp. ]
Store at 0°C | [form ]
Solid | [pka]
3.81±0.10(Predicted) | [color ]
White to off-white | [Optical Rotation]
Consistent with structure | [Water Solubility ]
Slightly soluble in water. | [InChI]
InChI=1S/C14H18BrNO4/c1-14(2,3)20-13(19)16-11(12(17)18)8-9-5-4-6-10(15)7-9/h4-7,11H,8H2,1-3H3,(H,16,19)(H,17,18)/t11-/m0/s1 | [InChIKey]
FBUDYESOPLBQIR-NSHDSACASA-N | [SMILES]
C(O)(=O)[C@H](CC1=CC=CC(Br)=C1)NC(OC(C)(C)C)=O | [CAS DataBase Reference]
82278-73-7(CAS DataBase Reference) |
Hazard Information | Back Directory | [Chemical Properties]
off-white powder | [Uses]
N-Boc-3-bromo-L-phenylalanine is used as pharmaceutical intermediate. | [Synthesis]
The general procedure for the synthesis of (S)-3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propionic acid from di-tert-butyl dicarbonate and (S)-2-amino-3-(3-bromophenyl)propionic acid was as follows: first, the reaction was carried out using sodium bicarbonate (3 eq.) and di-tert-butyl dicarbonate (Boc2O, 1.1 eq.) on the (S)-2-amino-3-(3-bromophenyl)propionic acid in a mixed solvent of dioxane and water. -(3-bromophenyl)propionic acid by tert-butoxycarbonyl (Boc) protection reaction to afford the Boc-protected intermediate 7 in 98% yield.Subsequently, the reaction was carried out in dimethylsulfoxide (DMSO) with cuprous iodide (0.4 eq.), cesium carbonate (0.5 eq.), L-proline (0.8 eq.), and sodium salt of methanesulfinic acid (3.9 eq.) as catalysts at 95-100 °C for 9 hours, during which two additional additions of cuprous iodide (0.2 eq.) and L-proline (0.4 eq.) were made, converting the brominated intermediate 7 to the methylsulfoxide-functionalized product 8 in 96% yield. Next, the carboxylic acid group of compound 8 was esterified to a benzyl ester using benzyl alcohol (1.1 eq.), 4-dimethylaminopyridine (DMAP, 0.1 eq.) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC, 1.0 eq.) to give compound 9 in 99% yield. Finally, a Boc deprotection reaction of the amino group was carried out by adding a dioxane solution of 4N HCl to a dichloromethane solution of compound 9 at 0 °C to give the target product 10 in the form of the HCl salt of the free amino group in 94% yield. | [References]
[1] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 3, p. 203 - 206 [2] Patent: WO2014/18748, 2014, A1. Location in patent: Paragraph 00120; 00121; 00122; 00123; 00124; 00125 [3] Catalysis Science and Technology, 2016, vol. 6, # 12, p. 4086 - 4089 [4] Patent: WO2009/102876, 2009, A1. Location in patent: Page/Page column 56 |
|
|